glabridin has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hsu, YL; Huang, MS; Hung, JY; Kuo, PL; Lien, CT; Tsai, YC; Tsai, YM; Wu, LY; Yang, CJ | 1 |
1 other study(ies) available for glabridin and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Glabridin inhibits migration, invasion, and angiogenesis of human non-small cell lung cancer A549 cells by inhibiting the FAK/rho signaling pathway.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Focal Adhesion Protein-Tyrosine Kinases; Humans; Integrin beta3; Isoflavones; Lung Neoplasms; Mice; Mice, Nude; Myosin Light Chains; Neovascularization, Pathologic; Phenols; Phosphorylation; rhoA GTP-Binding Protein; Signal Transduction; src-Family Kinases | 2011 |